Literature DB >> 14966558

The eosinophil enigma.

Timothy J Williams1.   

Abstract

Eosinophils accumulate in high numbers in the lungs of asthmatic patients. These cells have the ability to induce tissue damage, a capacity that relates to their traditional role in host defense against parasitic worms. On the other hand, eosinophils produce growth factors associated with tissue repair and remodeling, notably TGF-beta1. The relationship of these activities to lung dysfunction in asthma is highly controversial, but recent observations in humans and in animal models add spice to the debate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966558      PMCID: PMC338272          DOI: 10.1172/JCI21073

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  Eosinophils and interleukin-5: the debate continues.

Authors:  A Barry Kay; Andrew Menzies-Gow
Journal:  Am J Respir Crit Care Med       Date:  2003-06-15       Impact factor: 21.405

2.  Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.

Authors:  Patrick T Flood-Page; Andrew N Menzies-Gow; A Barry Kay; Douglas S Robinson
Journal:  Am J Respir Crit Care Med       Date:  2002-10-17       Impact factor: 21.405

Review 3.  The trials and tribulations of IL-5, eosinophils, and allergic asthma.

Authors:  P M O'Byrne; M D Inman; K Parameswaran
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

4.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Authors:  M J Leckie; A ten Brinke; J Khan; Z Diamant; B J O'Connor; C M Walls; A K Mathur; H C Cowley; K F Chung; R Djukanovic; T T Hansel; S T Holgate; P J Sterk; P J Barnes
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

5.  The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin.

Authors:  Simon Phipps; Sun Ying; Arun Wangoo; Yee-Ean Ong; Francesca Levi-Schaffer; A Barry Kay
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

6.  IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation.

Authors:  A Trifilieff; Y Fujitani; A J Coyle; M Kopf; C Bertrand
Journal:  Clin Exp Allergy       Date:  2001-06       Impact factor: 5.018

7.  Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody.

Authors:  D I Blyth; T F Wharton; M S Pedrick; T J Savage; S Sanjar
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

8.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.

Authors:  J S Munger; X Huang; H Kawakatsu; M J Griffiths; S L Dalton; J Wu; J F Pittet; N Kaminski; C Garat; M A Matthay; D B Rifkin; D Sheppard
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

9.  Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study.

Authors:  Johan C Kips; Brian J O'Connor; Stephen J Langley; Ashley Woodcock; Huib A M Kerstjens; Dirkje S Postma; Mel Danzig; Francis Cuss; Romain A Pauwels
Journal:  Am J Respir Crit Care Med       Date:  2003-03-20       Impact factor: 21.405

10.  Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.

Authors:  Joerg Mattes; Ming Yang; Surendran Mahalingam; Joachim Kuehr; Dianne C Webb; Ljubov Simson; Simon P Hogan; Aulikki Koskinen; Andrew N J McKenzie; Lindsay A Dent; Marc E Rothenberg; Klaus I Matthaei; Ian G Young; Paul S Foster
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  16 in total

1.  Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge.

Authors:  Rui He; Michiko K Oyoshi; Haoli Jin; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-24       Impact factor: 11.205

Review 2.  A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.

Authors:  M A Giembycz; M Kaur; R Leigh; R Newton
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

3.  Stimulation of the in vitro migration of ovine eosinophils by factors derived from the sheep scab mite, Psoroptes ovis.

Authors:  L A Wildblood; D G Jones
Journal:  Vet Res Commun       Date:  2006-12-23       Impact factor: 2.459

4.  Schistosoma mansoni infection in eosinophil lineage-ablated mice.

Authors:  Jonathan M Swartz; Kimberly D Dyer; Allen W Cheever; Thirumalai Ramalingam; Lesley Pesnicak; Joseph B Domachowske; James J Lee; Nancy A Lee; Paul S Foster; Thomas A Wynn; Helene F Rosenberg
Journal:  Blood       Date:  2006-06-13       Impact factor: 22.113

5.  Airway hyperresponsiveness in the absence of CD4+ T cells after primary but not secondary challenge.

Authors:  Anthony Joetham; Katsuyuki Takeda; Christian Taube; Nobuaki Miyahara; Arihiko Kanehiro; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2005-04-21       Impact factor: 6.914

6.  D-4F, an apoA-1 mimetic, decreases airway hyperresponsiveness, inflammation, and oxidative stress in a murine model of asthma.

Authors:  S D Nandedkar; D Weihrauch; H Xu; Y Shi; T Feroah; W Hutchins; D A Rickaby; N Duzgunes; C A Hillery; K S Konduri; K A Pritchard
Journal:  J Lipid Res       Date:  2010-12-03       Impact factor: 5.922

Review 7.  CD38 and airway hyper-responsiveness: studies on human airway smooth muscle cells and mouse models.

Authors:  Alonso G P Guedes; Deepak A Deshpande; Mythili Dileepan; Timothy F Walseth; Reynold A Panettieri; Subbaya Subramanian; Mathur S Kannan
Journal:  Can J Physiol Pharmacol       Date:  2014-12-09       Impact factor: 2.273

Review 8.  Cellular and molecular mechanisms of fibrosis.

Authors:  T A Wynn
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

9.  Histopathology of experimentally induced asthma in a murine model of sickle cell disease.

Authors:  Sandhya D Nandedkar; Thomas R Feroah; William Hutchins; Dorothee Weihrauch; Kameswari S Konduri; Jingli Wang; Robert C Strunk; Michael R DeBaun; Cheryl A Hillery; Kirkwood A Pritchard
Journal:  Blood       Date:  2008-06-25       Impact factor: 22.113

10.  Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice.

Authors:  Matthew L Renninger; Rosemarie E Seymour; Laurence O Whiteley; John P Sundberg; Harm Hogenesch
Journal:  Exp Dermatol       Date:  2009-07-23       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.